{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-11T01:49:24.746398+00:00","company":{"ticker":"DOCS","cik":1516513,"company_name":"Doximity, Inc."},"pagination":{"limit":100,"returned":20,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{},"facts":[{"fact_type":"earnings_release","fact_key":"0ac591fefa07a851bf463d98a508128b5389a93a","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2026-05-13T20:04:36+00:00","payload":{"eps_text":null,"guidance_signal":"initiated","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"fiscal quarter and year ended March 31, 2026","report_date":"2026-05-13","result_type":"reported_results","revenue_text":null},"claim":"Doximity, Inc. updated its fiscal quarter and year ended March 31, 2026 guidance (initiated).","evidence_excerpt":"On May 13, 2026 , Doximity, Inc. (“Doximity”) issued a press release announcing its financial results for its fiscal quarter and year ended March 31, 2026.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001516513-26-000017","anchor_url":"https://secwatch.observer/filing/0001516513-26-000017#claim-0ac591fefa07a851bf463d98a508128b5389a93a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651326000017/0001516513-26-000017-index.htm"},{"fact_type":"executive_change","fact_key":"1c7f5d42fa","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2026-05-13T20:04:36+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-05-13","interim":false,"role":"President","role_category":"president","successor_name":null,"successor_named":false},"claim":"Steven L. Zatz was appointed as President at Doximity, Inc..","evidence_excerpt":"Additionally, the Company announced the appointment of Steven L. Zatz, M.D. as President of the Company, effective May 13, 2026.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001516513-26-000017","anchor_url":"https://secwatch.observer/filing/0001516513-26-000017#claim-1c7f5d42fa","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651326000017/0001516513-26-000017-index.htm"},{"fact_type":"executive_change","fact_key":"5a339ed4de","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2026-05-13T20:04:36+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-05-13","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":true},"claim":"Matthew Sonefeldt was appointed as Chief Financial Officer at Doximity, Inc..","evidence_excerpt":"On May 13, 2026, Doximity, Inc. (the “Company”) announced the appointment of Matthew Sonefeldt as Chief Financial Officer of the Company, effective May 13, 2026.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001516513-26-000017","anchor_url":"https://secwatch.observer/filing/0001516513-26-000017#claim-5a339ed4de","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651326000017/0001516513-26-000017-index.htm"},{"fact_type":"executive_change","fact_key":"c38c0df6b8","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2025-06-13T23:59:59+00:00","payload":{"action":"step down","action_category":"role_change","departure_tone":"routine","effective_date":"2025-06-16","interim":false,"role":"Chief Strategy Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Nathan Gross changed role as Chief Strategy Officer at Doximity, Inc..","evidence_excerpt":"On June 10, 2025, Dr. Nathan Gross notified Doximity, Inc. (the “Company”) that he will step down from his role as Chief Strategy Officer to become an advisor to the Company, effective June 16, 2025.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001516513-25-000065","anchor_url":"https://secwatch.observer/filing/0001516513-25-000065#claim-c38c0df6b8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651325000065/0001516513-25-000065-index.htm"},{"fact_type":"earnings_release","fact_key":"563f2eb3ca26bb15248381f091b44c874d203cf8","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2024-05-16T23:59:59+00:00","payload":{"eps_text":"Diluted net income per share was $0.72","guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":"Net income of $147.6 million","period_text":"its fiscal year ended March 31, 2024","report_date":"2024-05-16","result_type":"reported_results","revenue_text":"Revenue of $475.4 million"},"claim":"Doximity, Inc. reported its fiscal year ended March 31, 2024 results: revenue Revenue of $475.4 million, net income Net income of $147.6 million, EPS Diluted net income per share was $0.72. Guidance reaffirmed.","evidence_excerpt":"and is incorporated by reference herein. \n\n--- EX-99.1 (EX-99.1) ---\n\nDoximity Announces Fourth Quarter and Fiscal Year 2024 Financial Results Fiscal year 2024 total revenues of $475.4 million, up 13% year-over-year Fiscal year 2024 net income growth of 31% and adjusted EBITDA growth of 25% year-over-year Q4 total revenues of $118.1 million, up 6% year-over-year Q4 net","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001516513-24-000019","anchor_url":"https://secwatch.observer/filing/0001516513-24-000019#claim-563f2eb3ca26bb15248381f091b44c874d203cf8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651324000019/0001516513-24-000019-index.htm"},{"fact_type":"earnings_release","fact_key":"ce2d6541f7df06ed9270ae12776f78db6748fa10","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2024-05-16T23:59:59+00:00","payload":{"eps_text":"Diluted net income per share was $0.20","guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":"Net income of $40.6 million","period_text":"its fiscal quarter ended March 31, 2024","report_date":"2024-05-16","result_type":"reported_results","revenue_text":"Revenue of $118.1 million"},"claim":"Doximity, Inc. reported its fiscal quarter ended March 31, 2024 results: revenue Revenue of $118.1 million, net income Net income of $40.6 million, EPS Diluted net income per share was $0.20. Guidance reaffirmed.","evidence_excerpt":"year 2024 total revenues of $475.4 million, up 13% year-over-year Fiscal year 2024 net income growth of 31% and adjusted EBITDA growth of 25% year-over-year Q4 total revenues of $118.1 million, up 6% year-over-year Q4 net income growth of 32% and adjusted EBITDA growth of 15% year-over-year SAN FRANCISCO, Calif., May 16, 2024 -- Doximity, Inc. (NYSE: DOCS), the leading","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001516513-24-000019","anchor_url":"https://secwatch.observer/filing/0001516513-24-000019#claim-ce2d6541f7df06ed9270ae12776f78db6748fa10","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651324000019/0001516513-24-000019-index.htm"},{"fact_type":"earnings_release","fact_key":"c540bdfa6f06cba64a3a86cd2f3fdea29acdc00c","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2024-02-08T23:59:59+00:00","payload":{"eps_text":"$0.24","guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"$48.0 million","period_text":"its fiscal quarter ended December 31, 2023","report_date":"2024-02-08","result_type":"reported_results","revenue_text":"$135.3 million"},"claim":"Doximity, Inc. reported its fiscal quarter ended December 31, 2023 results: revenue $135.3 million, net income $48.0 million, EPS $0.24. Guidance raised.","evidence_excerpt":"except as expressly set forth by specific reference in such filing. \n\n--- EX-99.1 (EX-99.1) ---\n\nDoximity Announces Fiscal 2024 Third Quarter Financial Results Total revenues of $135.3 million, up 17% year-over-year Net income margin of 35% and adjusted EBITDA margin of 54% Net income growth of 43% and adjusted EBITDA growth of 32% year-over-year SAN FRANCISCO, Calif.,","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001516513-24-000007","anchor_url":"https://secwatch.observer/filing/0001516513-24-000007#claim-c540bdfa6f06cba64a3a86cd2f3fdea29acdc00c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651324000007/0001516513-24-000007-index.htm"},{"fact_type":"earnings_release","fact_key":"77c57ad5480783d2a5c24dd98b1c32550c04a42e","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2023-11-09T23:59:59+00:00","payload":{"eps_text":"$0.15","guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":"$30.6 million","period_text":"fiscal 2024 second quarter ended September 30, 2023","report_date":"2023-11-09","result_type":"reported_results","revenue_text":"$113.6 million"},"claim":"Doximity, Inc. reported fiscal 2024 second quarter ended September 30, 2023 results: revenue $113.6 million, net income $30.6 million, EPS $0.15. Guidance reaffirmed.","evidence_excerpt":"as expressly set forth by specific reference in such filing. \n\n--- EX-99.1 (EX-99.1) ---\n\nDoximity Announces Fiscal 2024 Second Quarter Financial Results Total revenues of $113.6 million, up 11% year-over-year Net income margin of 27% and adjusted EBITDA margin of 48% Net income growth of 16% and adjusted EBITDA growth of 18% year-over-year SAN FRANCISCO, Calif.,","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001516513-23-000082","anchor_url":"https://secwatch.observer/filing/0001516513-23-000082#claim-77c57ad5480783d2a5c24dd98b1c32550c04a42e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651323000082/0001516513-23-000082-index.htm"},{"fact_type":"earnings_release","fact_key":"29e15e1c508b8f7a36391f8190700c7a0e05a2d1","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2023-08-08T23:59:59+00:00","payload":{"eps_text":"$0.13","guidance_signal":"unknown","item_codes_triggered":["2.02"],"net_income_text":"$28.4 million","period_text":"fiscal quarter ended June 30, 2023","report_date":"2023-08-08","result_type":"reported_results","revenue_text":"$108.5 million"},"claim":"Doximity, Inc. reported fiscal quarter ended June 30, 2023 results: revenue $108.5 million, net income $28.4 million, EPS $0.13.","evidence_excerpt":"• Revenue: Revenue of $108.5 million, versus $90.6 million, an increase of 20% year-over-year. • Net income and non-GAAP net income: Net income of $28.4 million, versus $22.4 million, representing a margin of 26.2%, versus 24.7%. Non-GAAP net income of $40.6 million, versus $30.8 million, representing a margin of 37.5%, versus 34.0%. • Adjusted EBITDA: Adjusted EBITDA of $46.6 million, versus $33.5 million, an increase of 39% year-over-year, representing adjusted EBITDA margins of 42.9%, versus 37.0%. • Diluted net income per share and non-GAAP diluted net income per share: Diluted net income per share was $0.13, versus $0.10, while non-GAAP diluted net income per share was $0.19, versus $0.14.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001516513-23-000066","anchor_url":"https://secwatch.observer/filing/0001516513-23-000066#claim-29e15e1c508b8f7a36391f8190700c7a0e05a2d1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651323000066/0001516513-23-000066-index.htm"},{"fact_type":"shareholder_vote","fact_key":"72ad46e4ad82a7b6dc96935f26eb9bc27e15415f","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2023-07-28T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-07-26","outcome":"passed","proposal_text":"Non-Binding Advisory Vote on the Frequency of Future Advisory Votes on Compensation","proposal_type":"say_on_pay_frequency","results":[{"broker_non_votes":"25923279","subject":null,"votes_abstain":"96280","votes_against":"0","votes_for":"614121088","votes_withheld":"0"}]},"claim":"Doximity, Inc. shareholders approved Non-Binding Advisory Vote on the Frequency of Future Advisory Votes on Compensation at the 2023-07-26 meeting.","evidence_excerpt":"Proposal Three – Non-Binding Advisory Vote on the Frequency of Future Advisory Votes on Compensation The stockholders’ preferred frequency of future advisory votes on the compensation of the Company’s named executive officers was “ one year .” The results of such vote were: ONE YEAR TWO YEARS THREE YEARS ABSTAIN BROKER NON-VOTES 614,121,088 22,930 1,070,509 96,280 25,923,279","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0001516513-23-000060","anchor_url":"https://secwatch.observer/filing/0001516513-23-000060#claim-72ad46e4ad82a7b6dc96935f26eb9bc27e15415f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651323000060/0001516513-23-000060-index.htm"},{"fact_type":"shareholder_vote","fact_key":"04bb5a14ce298a40ad7faa18d9a262ab6048a198","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2023-07-28T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-07-26","outcome":"passed","proposal_text":"Ratification of the Appointment of Independent Public Registered Accounting Firm","proposal_type":"auditor_ratification","results":[{"broker_non_votes":"0","subject":null,"votes_abstain":"37223","votes_against":"109986","votes_for":"641086877","votes_withheld":"0"}]},"claim":"Doximity, Inc. shareholders approved Ratification of the Appointment of Independent Public Registered Accounting Firm at the 2023-07-26 meeting.","evidence_excerpt":"Proposal Two – Ratification of the Appointment of Independent Public Registered Accounting Firm The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2024. The results of such vote were: FOR AGAINST ABSTAIN BROKER NON-VOTES 641,086,877 109,986 37,223 -","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0001516513-23-000060","anchor_url":"https://secwatch.observer/filing/0001516513-23-000060#claim-04bb5a14ce298a40ad7faa18d9a262ab6048a198","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651323000060/0001516513-23-000060-index.htm"},{"fact_type":"shareholder_vote","fact_key":"9dc9e913f05d104c096a69cde621fe2b956209d7","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2023-07-28T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-07-26","outcome":"passed","proposal_text":"Election of Directors","proposal_type":"director_election","results":[{"broker_non_votes":"25923279","subject":"Kevin Spain","votes_abstain":"0","votes_against":"0","votes_for":"585534059","votes_withheld":"29776748"},{"broker_non_votes":"25923279","subject":"Timothy Cabral","votes_abstain":"0","votes_against":"0","votes_for":"593512530","votes_withheld":"21798277"}]},"claim":"Doximity, Inc. shareholders approved Election of Directors at the 2023-07-26 meeting.","evidence_excerpt":"Proposal One – Election of Directors The stockholders elected each of the two persons named below as Class II directors to serve until the 2026 annual meeting of stockholders or until their successors are duly elected and qualified. The results of such vote were: FOR WITHHELD BROKER NON-VOTES Kevin Spain 585,534,059 29,776,748 25,923,279 Timothy Cabral 593,512,530 21,798,277 25,923,279","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0001516513-23-000060","anchor_url":"https://secwatch.observer/filing/0001516513-23-000060#claim-9dc9e913f05d104c096a69cde621fe2b956209d7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651323000060/0001516513-23-000060-index.htm"},{"fact_type":"earnings_release","fact_key":"cd4f52c279c0ea6ad4d177aec72b4bf399737367","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2023-05-16T23:59:59+00:00","payload":{"eps_text":"Diluted net income per share was $0.14","guidance_signal":"initiated","item_codes_triggered":["2.02"],"net_income_text":"Net income of $30.7 million","period_text":"fiscal quarter and year ended March 31, 2023","report_date":"2023-05-16","result_type":"reported_results","revenue_text":"Revenue of $111.0 million"},"claim":"Doximity, Inc. reported fiscal quarter and year ended March 31, 2023 results: revenue Revenue of $111.0 million, net income Net income of $30.7 million, EPS Diluted net income per share was $0.14. Guidance initiated.","evidence_excerpt":"in such filing. \n\n--- EX-99.1 (EX-99.1) ---\n\nDoximity Announces Fourth Quarter and Fiscal Year 2023 Financial Results and New Senior Leadership Hires Q4 total revenues of $111.0 million, up 18% year-over-year Q4 net income margin of 28% and adjusted EBITDA margin of 44% Fiscal year 2023 total revenues of $419.1 million, up 22% year-over-year Fiscal year 2023 net","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001516513-23-000028","anchor_url":"https://secwatch.observer/filing/0001516513-23-000028#claim-cd4f52c279c0ea6ad4d177aec72b4bf399737367","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651323000028/0001516513-23-000028-index.htm"},{"fact_type":"executive_change","fact_key":"29abc43e28","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2023-05-16T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2023-05-16","interim":false,"role":"Senior Vice President, Commercial Operations","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Craig Overpeck was appointed as Senior Vice President, Commercial Operations at Doximity, Inc..","evidence_excerpt":"On May 16, 2023, Doximity announced the appointment of Craig Overpeck as Senior Vice President, Commercial Operations.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001516513-23-000028","anchor_url":"https://secwatch.observer/filing/0001516513-23-000028#claim-29abc43e28","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651323000028/0001516513-23-000028-index.htm"},{"fact_type":"earnings_release","fact_key":"16f7911d73dab1be6608e587d76dd73af02a388b","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2023-02-09T23:59:59+00:00","payload":{"eps_text":"$0.16","guidance_signal":"lowered","item_codes_triggered":["2.02"],"net_income_text":"$33.5 million","period_text":"fiscal 2023 third quarter ended December 31, 2022","report_date":"2023-02-09","result_type":"reported_results","revenue_text":"$115.3 million"},"claim":"Doximity, Inc. reported fiscal 2023 third quarter ended December 31, 2022 results: revenue $115.3 million, net income $33.5 million, EPS $0.16. Guidance lowered.","evidence_excerpt":"Doximity Announces Fiscal 2023 Third Quarter Financial Results Total revenues of $115.3 million","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001516513-23-000007","anchor_url":"https://secwatch.observer/filing/0001516513-23-000007#claim-16f7911d73dab1be6608e587d76dd73af02a388b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651323000007/0001516513-23-000007-index.htm"},{"fact_type":"earnings_release","fact_key":"32e6c3d87fa7fdeee2cea02f34a57b15dee8af05","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2022-11-10T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"Fiscal year ending March 31, 2023","report_date":"2022-11-10","result_type":"guidance_update","revenue_text":"between $424.0 million and $432.0 million"},"claim":"Doximity, Inc. reported Fiscal year ending March 31, 2023 results: revenue between $424.0 million and $432.0 million. Guidance reaffirmed.","evidence_excerpt":"Doximity is reiterating its guidance for its fiscal year ending March 31, 2023 as follows: • Revenue between $424.0 million and $432.0 million. • Adjusted EBITDA between $178.0 million and $186.0 million.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001516513-22-000082","anchor_url":"https://secwatch.observer/filing/0001516513-22-000082#claim-32e6c3d87fa7fdeee2cea02f34a57b15dee8af05","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651322000082/0001516513-22-000082-index.htm"},{"fact_type":"earnings_release","fact_key":"775dd4c9d1a6af8d711ce5878d1977a1b8a8549b","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2022-11-10T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"initiated","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"Fiscal 2023 third quarter ending December 31, 2022","report_date":"2022-11-10","result_type":"guidance_update","revenue_text":"between $110.7 million and $111.7 million"},"claim":"Doximity, Inc. reported Fiscal 2023 third quarter ending December 31, 2022 results: revenue between $110.7 million and $111.7 million. Guidance initiated.","evidence_excerpt":"Doximity is providing guidance for its fiscal third quarter ending December 31, 2022 as follows: • Revenue between $110.7 million and $111.7 million. • Adjusted EBITDA between $47.7 million and $48.7 million.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001516513-22-000082","anchor_url":"https://secwatch.observer/filing/0001516513-22-000082#claim-775dd4c9d1a6af8d711ce5878d1977a1b8a8549b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651322000082/0001516513-22-000082-index.htm"},{"fact_type":"executive_change","fact_key":"2235a20bb3","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2022-08-04T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-08-02","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Phoebe L. Yang Watkin was appointed as Director at Doximity, Inc..","evidence_excerpt":"On August 2, 2022, the Board appointed Phoebe L. Yang Watkin to serve as a Class III director of the Board, filling the vacancy created by the departure of Dr. Kliman from the Board, effective immediately, until the annual meeting of the Doximity’s stockholders to be held in calendar 2024","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001516513-22-000070","anchor_url":"https://secwatch.observer/filing/0001516513-22-000070#claim-2235a20bb3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651322000070/0001516513-22-000070-index.htm"},{"fact_type":"executive_change","fact_key":"dcb0dfaa91","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2022-08-04T23:59:59+00:00","payload":{"action":"stepped down","action_category":"departure","departure_tone":"routine","effective_date":"2022-08-02","interim":false,"role":"Director","role_category":"director","successor_name":"Phoebe L. Yang Watkin","successor_named":true},"claim":"Gilbert Kliman departed as Director at Doximity, Inc..","evidence_excerpt":"On August 2, 2022, Gilbert Kliman, M.D. informed the board of directors (the \"Board\") of Doximity of his intention to step down from his role as a director on the Board, including his membership of the nominating and governance committee and the compensation committees of the Board, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001516513-22-000070","anchor_url":"https://secwatch.observer/filing/0001516513-22-000070#claim-dcb0dfaa91","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651322000070/0001516513-22-000070-index.htm"},{"fact_type":"executive_change","fact_key":"b9647cd628","cik":1516513,"ticker":"DOCS","company_name":"Doximity, Inc.","filed_at":"2022-02-08T23:59:59+00:00","payload":{"action":"retired","action_category":"departure","departure_tone":"retirement","effective_date":"2022-02-09","interim":false,"role":"Chief Commercial Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Joseph Kleine retired as Chief Commercial Officer at Doximity, Inc..","evidence_excerpt":"Joseph Kleine will retire from his role as Chief Commercial Officer and will become an advisor to the Chief Executive Officer, starting February 9, 2022.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001516513-22-000007","anchor_url":"https://secwatch.observer/filing/0001516513-22-000007#claim-b9647cd628","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1516513/000151651322000007/0001516513-22-000007-index.htm"}]}